Results 241 to 250 of about 1,049,628 (364)
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu+11 more
wiley +1 more source
Carbon dioxide solubility in polyethylene glycol polymer: an accurate intelligent estimation framework. [PDF]
Sead FF+9 more
europepmc +1 more source
INDIRECT MEASUREMENTS OF THE ROTATORY POWERS OF SOME ALPHA AND BETA FORMS OF THE SUGARS BY MEANS OF SOLUBILITY EXPERIMENTS. [PDF]
C. S. Hudson, E. Yanovsky
openalex +1 more source
MIF as an oncogenic driver of low‐heterogeneity melanomas
Shvefel and colleagues identified tumor‐secreted macrophage migration inhibitory factor (MIF) as an upregulated cytokine that mediates immune resistance in melanomas with low‐intratumoral heterogeneity. MIF and its functional paralogue D‐dopachrome tautomerase (D‐DT or MIF‐2) have overlapping but nonidentical signaling functions and are hypothesized to
Thuy T. Tran+4 more
wiley +1 more source
Advanced analysis on the correlation of salicylic acid solubility to solvent composition, temperature and pressure via machine learning approach. [PDF]
Mahdi WA, Alhowyan A, Obaidullah AJ.
europepmc +1 more source
THE CUTANEOUS REACTION TO SOLUBLE ANTIGEN-ANTIBODY COMPLEXES [PDF]
Charles G. Cochrane, William O. Weigle
openalex +1 more source
The soluble length of soluble linear groups
openaire +2 more sources
Solubility Enhancement Of Poorly Soluble Drug
The purpose of this evaluation was to enhance the solubility and bioavailability of poorly soluble medications through a variety of methods such as physical, chemical, and other modifications or techniques. Solubility refers to the maximum amount of solute that can dissolve in a specific amount of solvent or solution at a given temperature.
openaire +2 more sources
B‐cell chronic lymphocytic leukemia (B‐CLL) and monoclonal B‐cell lymphocytosis (MBL) show altered proteomes and phosphoproteomes, analyzed using mass spectrometry, protein microarrays, and western blotting. Identifying 2970 proteins and 316 phosphoproteins, including 55 novel phosphopeptides, we reveal BCR and NF‐kβ/STAT3 signaling in disease ...
Paula Díez+17 more
wiley +1 more source